KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Globus Medical (GMED) Shares Outstanding (Diluted Average) (2016 - 2020)

Historic Shares Outstanding (Diluted Average) for Globus Medical (GMED) over the last 10 years, with Q3 2020 value amounting to $100.8 million.

  • Globus Medical's Shares Outstanding (Diluted Average) fell 125.07% to $100.8 million in Q3 2020 from the same period last year, while for Sep 2020 it was $100.8 million, marking a year-over-year decrease of 125.07%. This contributed to the annual value of $102.0 million for FY2019, which is 67.31% up from last year.
  • As of Q3 2020, Globus Medical's Shares Outstanding (Diluted Average) stood at $100.8 million, which was down 125.07% from $101.0 million recorded in Q2 2020.
  • In the past 5 years, Globus Medical's Shares Outstanding (Diluted Average) ranged from a high of $102.1 million in Q1 2020 and a low of $96.3 million during Q1 2016
  • Over the past 5 years, Globus Medical's median Shares Outstanding (Diluted Average) value was $100.8 million (recorded in 2020), while the average stood at $99.6 million.
  • Per our database at Business Quant, Globus Medical's Shares Outstanding (Diluted Average) soared by 377.44% in 2018 and then plummeted by 125.07% in 2020.
  • Globus Medical's Shares Outstanding (Diluted Average) (Quarter) stood at $96.4 million in 2016, then rose by 1.51% to $97.9 million in 2017, then increased by 3.5% to $101.3 million in 2018, then rose by 0.67% to $102.0 million in 2019, then dropped by 1.15% to $100.8 million in 2020.
  • Its Shares Outstanding (Diluted Average) stands at $100.8 million for Q3 2020, versus $101.0 million for Q2 2020 and $102.1 million for Q1 2020.